PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引：0
|
作者：
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构：
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1097 / 1100
页数：4
相关论文
共 50 条
  • [31] PHASE-II TRIAL OF CISPLATIN IN THE TREATMENT OF PATIENTS WITH ADVANCED OR RECURRENT MIXED MESODERMAL SARCOMAS OF THE UTERUS - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    ORR, JW
    DISAIA, PJ
    CANCER TREATMENT REPORTS, 1986, 70 (02): : 271 - 274
  • [32] Phase II trial of bevacizumab in the treatment of recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Monk, B. J.
    Sill, M. W.
    Burger, R. A.
    Gray, H. J.
    Buekers, T. E.
    Roman, L. D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S21 - S22
  • [33] PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN PATIENTS WITH ADVANCED OR RECURRENT SQUAMOUS CARCINOMA OF THE CERVIX WHO HAD NEVER RECEIVED CHEMOTHERAPY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SUTTON, GP
    BLESSING, JA
    MCGUIRE, WP
    PATTON, T
    LOOK, KY
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (03) : 805 - 807
  • [34] PHASE-II TRIAL OF CISPLATIN AS 2-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    LAGASSE, LD
    DISAIA, PJ
    HOMESLEY, HD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03): : 253 - 256
  • [35] PHASE-II STUDY OF FLUDARABINE PHOSPHATE FOR THE TREATMENT OF ADVANCED NON-SMALL CELL-CARCINOMA OF THE LUNG - A SOUTHWEST ONCOLOGY GROUP-STUDY
    WEISS, GR
    CROWLEY, J
    VONHOFF, DD
    TAYLOR, SA
    BELT, RJ
    COLTMAN, CA
    HYNES, HE
    COSTANZI, JJ
    CANCER TREATMENT REPORTS, 1986, 70 (09): : 1123 - 1124
  • [36] ECHINOMYCIN (NSC 526417) IN RECURRENT AND METASTATIC NONSQUAMOUS CELL-CARCINOMA OF THE CERVIX - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
    MUSS, HB
    BLESSING, JA
    HANJANI, P
    MALFETANO, JH
    KEMP, GM
    WEBSTER, K
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (04): : 363 - 364
  • [37] A Phase II Trial of Erlotinib in Recurrent Squamous Cell Carcinoma of the Cervix A Gynecologic Oncology Group Study
    Schilder, Russell J.
    Sill, Michael W.
    Lee, Yi-Chun
    Mannel, Robert
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (05) : 929 - 933
  • [38] A PHASE-II STUDY OF CARBOPLATIN AND CISPLATIN IN ADVANCED OR RECURRENT SQUAMOUS CARCINOMA OF THE UTERINE CERVIX
    MORRIS, M
    GERSHENSON, DM
    BURKE, TW
    MITCHELL, MF
    LEVENBACK, C
    ATKINSON, N
    WHARTON, JT
    GYNECOLOGIC ONCOLOGY, 1994, 53 (02) : 234 - 238
  • [39] A PHASE-II EVALUATION OF MITOLACTOL IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    STEHMAN, FB
    BLESSING, JA
    MCGEHEE, R
    BARRETT, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (12) : 1892 - 1895
  • [40] PHASE-II TRIAL OF DICHLOROMETHOTREXATE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    ROBERTS, JA
    BLESSING, JA
    MCGEHEE, R
    BEECHAM, J
    HOMESLEY, HD
    CANCER TREATMENT REPORTS, 1987, 71 (12): : 1295 - 1296
12345